Medicines Australia is committed to the transparency of its conduct in administering the Code of Conduct. As required in the Code, Medicines Australia publishes information about complaints considered by the Code and Appeals Committee.
Complaint 1163 – OZEMPIC Media Activity, published November 2021
Complaint 1162 – RINVOQ Promotional Material, published May 2021
Complaints 1159 – 1161, published December 2020
Complaints 1154 – 1158, published December 2019
Complaint 1153, published September 2019
Prior to September 2019, the Code of Conduct annual reports cover the complaints processed. These are available below for your convenience.
Contact information & confidentiality
Members of the Code of Conduct committees will not discuss complaints with a healthcare professional, member of the general public or pharmaceutical company.
All questions relating to particular complaints or the Code of Conduct more broadly should be directed to the Secretary of the Code of Conduct Committee at Medicines Australia.
Phone: (02) 6147 6500